Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
American Journal of Physiology. Cell Physiology|September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesisJunjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
Anticancer Research|May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10Yumi Otoyama, Jun Arai, Kaku Goto, et al.
BMC Cancer|April 21, 2022
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancerJun Arai, Yumi Otoyama, Ken-Ichi Fujita, et al.
Clinical Nephrology|June 25, 2019
Significance of urinary albumin excretion in patients with cast nephropathyRyo Nakagawa, Aya Imafuku, Eiko Hasegawa, et al.
Iscience|February 17, 2023
Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancerTakahiro Seimiya, Tatsunori Suzuki, Takuma Iwata, et al.
BMC Cancer|November 14, 2019
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinomaTakahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.
Circulation|July 22, 2018
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 InhibitionToru Hashimoto, Grace E Kim, Richard S Tunin, et al.
Cancers|May 24, 2020
A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal AdenocarcinomaToshio Fujisawa, Takeshi Shimamura, Kaku Goto, et al.
Oncology Letters|August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancerYushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Pageof 9